Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Impact of multidisciplinary navigation services on timely treatment initiation: A difference-in-differences analysis.

163 Background: Patients with a new cancer diagnosis encounter social, structural, and clinical barriers that can delay treatment initiation. Patient navigation programs have been shown to improve cancer treatment timeliness, but few studies have utilized a multidisciplinary approach. NYU Langone Health (NYULH)...

Taylor M. McCready, Daniel Louie, Patrizia Bernard et al. · 0 citations
Sep 2026

Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

A phase II trial assessed the safety and efficacy of pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin (pembrolizumab-GVD) in transplant-eligible patients with relapsed/refractory (rel/rel) cHL, and demonstrated a complete response (CR) rate of 95% and progression-free survival (PFS) of 100% at 13.5 mo...

K. Patel, G. Shah, H. Schöder et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.